European Journal of Contraception and Reproductive Health Care

Papers
(The H4-Index of European Journal of Contraception and Reproductive Health Care is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
COVID 19 era: a beginning of upsurge in unwanted pregnancies, unmet need for contraception and other women related issues48
Sexual activity and contraceptive use during social distancing and self-isolation in the COVID-19 pandemic46
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?38
Does SARS-CoV-2 infection cause sperm DNA fragmentation? Possible link with oxidative stress32
Fertility preservation in female cancer sufferers: (only) a moral obligation?31
Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17β-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial throm30
Factors influencing contraception choice and use globally: a synthesis of systematic reviews24
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception23
Prevalence and correlates of menstrual hygiene practices among young currently married women aged 15–24 years: an analysis from a nationally representative survey of India23
Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature20
Contraceptive use and pregnancy plans among women of reproductive age during the first Australian COVID-19 lockdown: findings from an online survey20
Slow implementation of mifepristone medical termination of pregnancy in Quebec, Canada: a qualitative investigation17
Comparative pharmacokinetic analysis of levonorgestrel-releasing intrauterine systems and levonorgestrel-containing contraceptives with oral or subdermal administration route17
Non-pharmacological anxiety reduction with immersive virtual reality for first-trimester dilation and curettage: a pilot study16
Family planning: an essential health activity in the pandemic of SARS-CoV-214
Impact of COVID-19 on reproductive health and maternity services in low resource countries14
Copper IUD continuation, unwanted effects and cost consequences at 1 year in users aged under 30 – a secondary analysis of the EURAS-IUD study14
0.017765998840332